{"id":"W1974862201","doi":"10.1038/sj.leu.2403928","title":"Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients","year":2005,"lang":"en","type":"letter","venue":"Leukemia","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"","keywords":"Imatinib; Myeloid leukemia; Medicine; Internal medicine; Leukemia; Imatinib mesylate; Myeloid; Hematology; Cancer research; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0004257434,0.002218373,0.00287413,0.001410179,0.0003773694,0.000158534,0.001423597,0.002889088,0.002625632],"category_scores_gemma":[0.0007813388,0.002183314,0.0006469942,0.001738375,0.0002242726,0.0002006095,0.0007043754,0.006613335,0.002318448],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.08722208,"about_ca_system_score_gemma":0.02953967,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02066343,"about_ca_topic_score_gemma":0.002190121,"domain_scores_codex":[0.9888549,0.0004776432,0.002564931,0.002839716,0.002203938,0.003058887],"domain_scores_gemma":[0.9926828,0.0005180474,0.0009727149,0.00360973,0.0003380843,0.001878608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000622081,0.0001383767,0.003483715,0.0007341485,0.0003964867,0.002249795,0.001114397,0.0005904289,0.005180779,0.00000426948,0.9716255,0.01386004],"study_design_scores_gemma":[0.04046892,0.001285321,0.0289651,0.005163986,0.001012674,0.000419645,0.00006256554,0.0008135453,0.001881058,0.00006723678,0.9172698,0.002590197],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.8484586,0.001733396,0.00001837191,0.1280375,0.00188467,0.007086738,0.001062464,0.0006536422,0.0110647],"genre_scores_gemma":[0.1883474,0.000924655,0.006412532,0.5740771,0.01764993,0.001430069,0.01957279,0.001855371,0.1897301],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6601111,"threshold_uncertainty_score":0.9990556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02552313955703081,"score_gpt":0.2673035791016141,"score_spread":0.2417804395445833,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}